This site uses cookies. To learn more, please visit our Privacy Policy. By continuing to surf on our website, you consent to our use of cookies Close [X]
Parathyroid disorders lead to abnormal levels of calcium in the blood that causes brittle bones, kidney stones, fatigue, weakness, and other problems. A parathyroid adenoma is a tumor on one of your parathyroid glands. These are four small glands located near or at the back of your thyroid gland that produce parathyroid hormone (PTH). This hormone helps control the amount of calcium and phosphorus in your blood. MARKET DYNAMICS
The parathyroid disorders market is anticipated to grow in the market by rising prevalence of parathyroid disorders, increasing government assistance, rising healthcare expenditure, growing geriatric population is boosting the growth of the market. However, challenges in research and development, side-effects of treatment, the presence of misbranded and spurious drugs, expiration of patented drugs, and poor healthcare system in low and middle-income countries may restrain the market growth. MARKET SCOPE
The "Parathyroid Disorders Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of in parathyroid disorders market with detailed market segmentation by type, diagnosis, treatment, end user and geography. The parathyroid disorders market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in parathyroid disorders market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The parathyroid disorders market is segmented on the basis of type, diagnosis, treatment and by end user. Based on type the market is segmented as hyperparathyroidism (HPT), parathyroid cancer and hypoparathyroidism. On the basis of diagnosis the market is categorized as blood tests, imaging tests and urine tests. On the basis of treatment the market is categorized as surgery, radiation therapy, drugs and others. On the basis of end user the market is categorized as hospitals and clinics, diagnostic centers, drug stores, pharmacies and others.
Get more information on this report :
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in parathyroid disorders market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The parathyroid disorders market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting parathyroid disorders market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the parathyroid disorders market in these regions.
Get more information on this report :
MARKET PLAYERS
The report covers key developments in the in parathyroid disorders market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in parathyroid disorders market are anticipated to have lucrative growth opportunities in the future with the rising demand for in parathyroid disorders market in the global market. Below mentioned is the list of few companies engaged in the Parathyroid Disorders market.
The report also includes the profiles of key in parathyroid disorders market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Alcon Laboratories, Inc.
Amgen Inc.
Bayer Healthcare
Becton
Dickinson and Company
Ethicon, Inc.
Medtronic
Merck
Smith & Nephew plc
Teva Pharmaceutical Industries Ltd.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
TABLE OF CONTENTS
1. INTRODUCTION 1.1. SCOPE OF THE STUDY 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 1.3. MARKET SEGMENTATION 1.3.1 Parathyroid Disorders Market - By Type 1.3.2 Parathyroid Disorders Market - By Diagnosis 1.3.3 Parathyroid Disorders Market - By Treatment 1.3.4 Parathyroid Disorders Market - By End User 1.3.5 Parathyroid Disorders Market - By Region 1.3.5.1 By Country 2. KEY TAKEAWAYS 3. RESEARCH METHODOLOGY 4. PARATHYROID DISORDERS MARKET LANDSCAPE 4.1. OVERVIEW 4.2. PEST ANALYSIS 4.2.1 North America - Pest Analysis 4.2.2 Europe - Pest Analysis 4.2.3 Asia-Pacific - Pest Analysis 4.2.4 Middle East and Africa - Pest Analysis 4.2.5 South and Central America - Pest Analysis 4.3. EXPERT OPINIONS 5. PARATHYROID DISORDERS MARKET - KEY MARKET DYNAMICS 5.1. KEY MARKET DRIVERS 5.2. KEY MARKET RESTRAINTS 5.3. KEY MARKET OPPORTUNITIES 5.4. FUTURE TRENDS 5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC 6. PARATHYROID DISORDERS MARKET - GLOBAL MARKET ANALYSIS 6.1. PARATHYROID DISORDERS - GLOBAL MARKET OVERVIEW 6.2. PARATHYROID DISORDERS - GLOBAL MARKET AND FORECAST TO 2028 6.3. MARKET POSITIONING/MARKET SHARE 7. PARATHYROID DISORDERS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE 7.1. OVERVIEW 7.2. TYPE MARKET FORECASTS AND ANALYSIS 7.3. HYPERPARATHYROIDISM (HPT) 7.3.1. Overview 7.3.2. Hyperparathyroidism (HPT) Market Forecast and Analysis 7.4. PARATHYROID CANCER 7.4.1. Overview 7.4.2. Parathyroid Cancer Market Forecast and Analysis 7.5. HYPOPARATHYROIDISM 7.5.1. Overview 7.5.2. Hypoparathyroidism Market Forecast and Analysis 8. PARATHYROID DISORDERS MARKET - REVENUE AND FORECASTS TO 2028 - DIAGNOSIS 8.1. OVERVIEW 8.2. DIAGNOSIS MARKET FORECASTS AND ANALYSIS 8.3. BLOOD TESTS 8.3.1. Overview 8.3.2. Blood Tests Market Forecast and Analysis 8.4. IMAGING TESTS 8.4.1. Overview 8.4.2. Imaging Tests Market Forecast and Analysis 8.5. URINE TESTS 8.5.1. Overview 8.5.2. Urine Tests Market Forecast and Analysis 9. PARATHYROID DISORDERS MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT 9.1. OVERVIEW 9.2. TREATMENT MARKET FORECASTS AND ANALYSIS 9.3. SURGERY 9.3.1. Overview 9.3.2. Surgery Market Forecast and Analysis 9.4. RADIATION THERAPY 9.4.1. Overview 9.4.2. Radiation Therapy Market Forecast and Analysis 9.5. DRUGS 9.5.1. Overview 9.5.2. Drugs Market Forecast and Analysis 9.6. OTHERS 9.6.1. Overview 9.6.2. Others Market Forecast and Analysis 10. PARATHYROID DISORDERS MARKET - REVENUE AND FORECASTS TO 2028 - END USER 10.1. OVERVIEW 10.2. END USER MARKET FORECASTS AND ANALYSIS 10.3. HOSPITALS AND CLINICS 10.3.1. Overview 10.3.2. Hospitals and Clinics Market Forecast and Analysis 10.4. DIAGNOSTIC CENTERS 10.4.1. Overview 10.4.2. Diagnostic Centers Market Forecast and Analysis 10.5. DRUG STORES 10.5.1. Overview 10.5.2. Drug Stores Market Forecast and Analysis 10.6. PHARMACIES 10.6.1. Overview 10.6.2. Pharmacies Market Forecast and Analysis 10.7. OTHERS 10.7.1. Overview 10.7.2. Others Market Forecast and Analysis 11. PARATHYROID DISORDERS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS 11.1. NORTH AMERICA 11.1.1 North America Parathyroid Disorders Market Overview 11.1.2 North America Parathyroid Disorders Market Forecasts and Analysis 11.1.3 North America Parathyroid Disorders Market Forecasts and Analysis - By Type 11.1.4 North America Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis 11.1.5 North America Parathyroid Disorders Market Forecasts and Analysis - By Treatment 11.1.6 North America Parathyroid Disorders Market Forecasts and Analysis - By End User 11.1.7 North America Parathyroid Disorders Market Forecasts and Analysis - By Countries 11.1.7.1 United States Parathyroid Disorders Market 11.1.7.1.1 United States Parathyroid Disorders Market by Type 11.1.7.1.2 United States Parathyroid Disorders Market by Diagnosis 11.1.7.1.3 United States Parathyroid Disorders Market by Treatment 11.1.7.1.4 United States Parathyroid Disorders Market by End User 11.1.7.2 Canada Parathyroid Disorders Market 11.1.7.2.1 Canada Parathyroid Disorders Market by Type 11.1.7.2.2 Canada Parathyroid Disorders Market by Diagnosis 11.1.7.2.3 Canada Parathyroid Disorders Market by Treatment 11.1.7.2.4 Canada Parathyroid Disorders Market by End User 11.1.7.3 Mexico Parathyroid Disorders Market 11.1.7.3.1 Mexico Parathyroid Disorders Market by Type 11.1.7.3.2 Mexico Parathyroid Disorders Market by Diagnosis 11.1.7.3.3 Mexico Parathyroid Disorders Market by Treatment 11.1.7.3.4 Mexico Parathyroid Disorders Market by End User 11.2. EUROPE 11.2.1 Europe Parathyroid Disorders Market Overview 11.2.2 Europe Parathyroid Disorders Market Forecasts and Analysis 11.2.3 Europe Parathyroid Disorders Market Forecasts and Analysis - By Type 11.2.4 Europe Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis 11.2.5 Europe Parathyroid Disorders Market Forecasts and Analysis - By Treatment 11.2.6 Europe Parathyroid Disorders Market Forecasts and Analysis - By End User 11.2.7 Europe Parathyroid Disorders Market Forecasts and Analysis - By Countries 11.2.7.1 Germany Parathyroid Disorders Market 11.2.7.1.1 Germany Parathyroid Disorders Market by Type 11.2.7.1.2 Germany Parathyroid Disorders Market by Diagnosis 11.2.7.1.3 Germany Parathyroid Disorders Market by Treatment 11.2.7.1.4 Germany Parathyroid Disorders Market by End User 11.2.7.2 France Parathyroid Disorders Market 11.2.7.2.1 France Parathyroid Disorders Market by Type 11.2.7.2.2 France Parathyroid Disorders Market by Diagnosis 11.2.7.2.3 France Parathyroid Disorders Market by Treatment 11.2.7.2.4 France Parathyroid Disorders Market by End User 11.2.7.3 Italy Parathyroid Disorders Market 11.2.7.3.1 Italy Parathyroid Disorders Market by Type 11.2.7.3.2 Italy Parathyroid Disorders Market by Diagnosis 11.2.7.3.3 Italy Parathyroid Disorders Market by Treatment 11.2.7.3.4 Italy Parathyroid Disorders Market by End User 11.2.7.4 Spain Parathyroid Disorders Market 11.2.7.4.1 Spain Parathyroid Disorders Market by Type 11.2.7.4.2 Spain Parathyroid Disorders Market by Diagnosis 11.2.7.4.3 Spain Parathyroid Disorders Market by Treatment 11.2.7.4.4 Spain Parathyroid Disorders Market by End User 11.2.7.5 United Kingdom Parathyroid Disorders Market 11.2.7.5.1 United Kingdom Parathyroid Disorders Market by Type 11.2.7.5.2 United Kingdom Parathyroid Disorders Market by Diagnosis 11.2.7.5.3 United Kingdom Parathyroid Disorders Market by Treatment 11.2.7.5.4 United Kingdom Parathyroid Disorders Market by End User 11.3. ASIA-PACIFIC 11.3.1 Asia-Pacific Parathyroid Disorders Market Overview 11.3.2 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis 11.3.3 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By Type 11.3.4 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis 11.3.5 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By Treatment 11.3.6 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By End User 11.3.7 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By Countries 11.3.7.1 Australia Parathyroid Disorders Market 11.3.7.1.1 Australia Parathyroid Disorders Market by Type 11.3.7.1.2 Australia Parathyroid Disorders Market by Diagnosis 11.3.7.1.3 Australia Parathyroid Disorders Market by Treatment 11.3.7.1.4 Australia Parathyroid Disorders Market by End User 11.3.7.2 China Parathyroid Disorders Market 11.3.7.2.1 China Parathyroid Disorders Market by Type 11.3.7.2.2 China Parathyroid Disorders Market by Diagnosis 11.3.7.2.3 China Parathyroid Disorders Market by Treatment 11.3.7.2.4 China Parathyroid Disorders Market by End User 11.3.7.3 India Parathyroid Disorders Market 11.3.7.3.1 India Parathyroid Disorders Market by Type 11.3.7.3.2 India Parathyroid Disorders Market by Diagnosis 11.3.7.3.3 India Parathyroid Disorders Market by Treatment 11.3.7.3.4 India Parathyroid Disorders Market by End User 11.3.7.4 Japan Parathyroid Disorders Market 11.3.7.4.1 Japan Parathyroid Disorders Market by Type 11.3.7.4.2 Japan Parathyroid Disorders Market by Diagnosis 11.3.7.4.3 Japan Parathyroid Disorders Market by Treatment 11.3.7.4.4 Japan Parathyroid Disorders Market by End User 11.3.7.5 South Korea Parathyroid Disorders Market 11.3.7.5.1 South Korea Parathyroid Disorders Market by Type 11.3.7.5.2 South Korea Parathyroid Disorders Market by Diagnosis 11.3.7.5.3 South Korea Parathyroid Disorders Market by Treatment 11.3.7.5.4 South Korea Parathyroid Disorders Market by End User 11.4. MIDDLE EAST AND AFRICA 11.4.1 Middle East and Africa Parathyroid Disorders Market Overview 11.4.2 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis 11.4.3 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By Type 11.4.4 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis 11.4.5 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By Treatment 11.4.6 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By End User 11.4.7 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By Countries 11.4.7.1 South Africa Parathyroid Disorders Market 11.4.7.1.1 South Africa Parathyroid Disorders Market by Type 11.4.7.1.2 South Africa Parathyroid Disorders Market by Diagnosis 11.4.7.1.3 South Africa Parathyroid Disorders Market by Treatment 11.4.7.1.4 South Africa Parathyroid Disorders Market by End User 11.4.7.2 Saudi Arabia Parathyroid Disorders Market 11.4.7.2.1 Saudi Arabia Parathyroid Disorders Market by Type 11.4.7.2.2 Saudi Arabia Parathyroid Disorders Market by Diagnosis 11.4.7.2.3 Saudi Arabia Parathyroid Disorders Market by Treatment 11.4.7.2.4 Saudi Arabia Parathyroid Disorders Market by End User 11.4.7.3 U.A.E Parathyroid Disorders Market 11.4.7.3.1 U.A.E Parathyroid Disorders Market by Type 11.4.7.3.2 U.A.E Parathyroid Disorders Market by Diagnosis 11.4.7.3.3 U.A.E Parathyroid Disorders Market by Treatment 11.4.7.3.4 U.A.E Parathyroid Disorders Market by End User 11.5. SOUTH AND CENTRAL AMERICA 11.5.1 South and Central America Parathyroid Disorders Market Overview 11.5.2 South and Central America Parathyroid Disorders Market Forecasts and Analysis 11.5.3 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By Type 11.5.4 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis 11.5.5 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By Treatment 11.5.6 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By End User 11.5.7 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By Countries 11.5.7.1 Brazil Parathyroid Disorders Market 11.5.7.1.1 Brazil Parathyroid Disorders Market by Type 11.5.7.1.2 Brazil Parathyroid Disorders Market by Diagnosis 11.5.7.1.3 Brazil Parathyroid Disorders Market by Treatment 11.5.7.1.4 Brazil Parathyroid Disorders Market by End User 11.5.7.2 Argentina Parathyroid Disorders Market 11.5.7.2.1 Argentina Parathyroid Disorders Market by Type 11.5.7.2.2 Argentina Parathyroid Disorders Market by Diagnosis 11.5.7.2.3 Argentina Parathyroid Disorders Market by Treatment 11.5.7.2.4 Argentina Parathyroid Disorders Market by End User 12. INDUSTRY LANDSCAPE 12.1. MERGERS AND ACQUISITIONS 12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES 12.3. NEW PRODUCT LAUNCHES 12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS 13. PARATHYROID DISORDERS MARKET, KEY COMPANY PROFILES 13.1. ALCON LABORATORIES, INC. 13.1.1. Key Facts 13.1.2. Business Description 13.1.3. Products and Services 13.1.4. Financial Overview 13.1.5. SWOT Analysis 13.1.6. Key Developments 13.2. AMGEN INC. 13.2.1. Key Facts 13.2.2. Business Description 13.2.3. Products and Services 13.2.4. Financial Overview 13.2.5. SWOT Analysis 13.2.6. Key Developments 13.3. BAYER HEALTHCARE 13.3.1. Key Facts 13.3.2. Business Description 13.3.3. Products and Services 13.3.4. Financial Overview 13.3.5. SWOT Analysis 13.3.6. Key Developments 13.4. BECTON 13.4.1. Key Facts 13.4.2. Business Description 13.4.3. Products and Services 13.4.4. Financial Overview 13.4.5. SWOT Analysis 13.4.6. Key Developments 13.5. DICKINSON AND COMPANY 13.5.1. Key Facts 13.5.2. Business Description 13.5.3. Products and Services 13.5.4. Financial Overview 13.5.5. SWOT Analysis 13.5.6. Key Developments 13.6. ETHICON, INC. 13.6.1. Key Facts 13.6.2. Business Description 13.6.3. Products and Services 13.6.4. Financial Overview 13.6.5. SWOT Analysis 13.6.6. Key Developments 13.7. MEDTRONIC 13.7.1. Key Facts 13.7.2. Business Description 13.7.3. Products and Services 13.7.4. Financial Overview 13.7.5. SWOT Analysis 13.7.6. Key Developments 13.8. MERCK 13.8.1. Key Facts 13.8.2. Business Description 13.8.3. Products and Services 13.8.4. Financial Overview 13.8.5. SWOT Analysis 13.8.6. Key Developments 13.9. SMITH AND NEPHEW PLC 13.9.1. Key Facts 13.9.2. Business Description 13.9.3. Products and Services 13.9.4. Financial Overview 13.9.5. SWOT Analysis 13.9.6. Key Developments 13.10. TEVA PHARMACEUTICAL INDUSTRIES LTD. 13.10.1. Key Facts 13.10.2. Business Description 13.10.3. Products and Services 13.10.4. Financial Overview 13.10.5. SWOT Analysis 13.10.6. Key Developments 14. APPENDIX 14.1. ABOUT THE INSIGHT PARTNERS 14.2. GLOSSARY OF TERMS
The List of Companies
1. Alcon Laboratories, Inc. 2. Amgen Inc. 3. Bayer Healthcare 4. Becton 5. Dickinson and Company 6. Eli Lilly, Ethicon, Inc. 7. Medtronic 8. Merck 9. Smith & Nephew plc 10. Teva Pharmaceutical Industries Ltd.
